搜尋結果
華富國際委任穆得志先生為獨立非執行董事. 香港, 2009年10月27日 - (亞太商訊) - 香港著名金融服務集團華富國際控股有限公司（「華富國際」，股份代號：952.hk）於今天正式委任穆得志先生（Mr Douglas Howard Moore）為華富國際之獨立非執行董事，並同時委任為薪酬 ...
Lanifibranor is China's first oral MASH drug to enter Phase III clinical trials and is expected to fill the gap in China's MASH market. HONG KONG, Aug 14, 2024 - (ACN Newswire) - Sino Biopharmaceutical Limited (“Sino Biopharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation ...
2024年5月24日 · 第九届【华富卓越投资者关系大奖】颁奖典礼圆满举行. 香港, 2024年5月24日 - (亚太商讯) - 「华富卓越投资者关系大奖2023」（简称「大奖」）于2024年5月24日假香港四季酒店 (Four Seasons Hotel Hong Kong) 顺利举行，表扬在多变的环境下能与时并进的投资者关系 ...
2024年8月2日 · SINGAPORE, Aug 2, 2024 - (ACN Newswire) - SMI Vantage Limited (SGX: Y45) (“SMI” or the “Company”), a company listed on the mainboard of the SGX and The9 Limited (Nasdaq: NCTY) (“The9”), is pleased to announce the signing of a Cooperation Agreement to strengthen their partnership in Bitcoin (BTC) mining and identify new opportunities for collabor...
2021年7月15日 · NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round.
Future Outlook. Looking ahead, the Group will continue to gain insights into user needs, enrich the social product matrix, and solidify competitive advantages through matrix-based synergy while exploring new growth points through innovation.
2024年5月17日 · These two awards affirm CITIC Telecom CPC's “Innovation Never Stops” vision and pursuit of excellence, showcasing the outstanding achievements of its innovation team in DICT technologies, while demonstrating its “AI+ Cloud Network Security” integrated platform capabilities, staying ahead of the curve with its international ...
